Vor Biopharma (VOR) Other Working Capital Changes (2020 - 2026)
Vor Biopharma (VOR) posted quarterly Other Working Capital Changes of -$61000.0 for Q1 2026, up 94.18% year-over-year from -$31414.3 in Q1 2025, and down 3.39% quarter-over-quarter from -$59000.0 in Q4 2025.
Powered by 
Analysis
Vor Biopharma (VOR) Other Working Capital Changes (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has reported Other Working Capital Changes for 7 consecutive years, with -$61000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 94.18% year-over-year to -$61000.0; the TTM figure through Mar 2026 stood at -$1.4 million (up 64.14% YoY), while the FY2025 annual figure was -$2.4 million, up 37.18% from the prior year.
- Other Working Capital Changes eased to -$61000.0 in Q1 2026 per VOR's latest filing, from -$59000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $3.4 million in Q3 2023 and bottomed at -$2.6 million in Q2 2025.
- Historically, Other Working Capital Changes has averaged $49000.0 across 5 years, with a median of -$7000.0 in 2023.
- Annual changes were most pronounced in 2022 — Other Working Capital Changes slumped 4443.75% — and 2025, when it jumped 97.93%.
- Vor Biopharma's Other Working Capital Changes stood at -$1.4 million in 2022, then soared by 33.87% to -$937000.0 in 2023, then dropped by 9.28% to -$1.0 million in 2024, then jumped by 94.24% to -$59000.0 in 2025, then declined by 3.39% to -$61000.0 in 2026.
- Business Quant data shows VOR's Other Working Capital Changes at -$61000.0 in Q1 2026, -$59000.0 in Q4 2025, and -$20000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Vor Biopharma | 1.36 Bn | 1.36 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -278,000.00 |
| Jun 30, 2026 | -278,000.00 |
| Mar 31, 2026 | 6.36 Mn |
| Mar 31, 2026 | 6.36 Mn |
| Dec 31, 2025 | 151,000.00 |
| Dec 31, 2025 | 151,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Jun 30, 2025 | -1.58 Mn |
| Jun 30, 2025 | -1.58 Mn |
| Mar 31, 2025 | -1.05 Mn |
| Mar 31, 2025 | -1.05 Mn |
| Dec 31, 2024 | -1.02 Mn |
| Dec 31, 2024 | -1.02 Mn |
| Sep 30, 2024 | -966,000.00 |
| Sep 30, 2024 | -966,000.00 |
| Jun 30, 2024 | -919,000.00 |
| Jun 30, 2024 | -919,000.00 |
| Mar 31, 2024 | -921,000.00 |
| Mar 31, 2024 | -921,000.00 |